Category: Accuray Inc.
Fujifilm Holdings closes its nearly $1 billion buyout of SonoSite; also, Orchid closes buyout of Sandvik's medical solutions biz; Derma Sciences drops $15M on MedEfficiency; Pentax expands endoscopy ops; Accuray signs German R&D deal; GE Healthcare plans to expand in China; and analysts' ups and downs.
Fujifilm Holdings (TSE:4901) said it closed its $54-per-share acquisition of SonoSite (NSDQ: SONO).
, Derma Sciences Inc.
, Digital Endoscopy GmbH
, Fujifilm Holdings
, HOYA ConBio
, Johnson & Johnson
, McKesson Corp.
, Orchid Orthopedic
, University of Heidelberg
, Abbott Laboratories
, Accuray Inc.
, Allergan Inc.
, GE Healthcare
Accuray CEO Euan Thomson tells MassDevice about being a small fish in a big pond, managing growing pains and his strategies for breaking out in a well-established market.
When Euan Thomson landed in the corner office at radiosurgery device maker Accuray (NSDQ:ARAY) in 2002, the company was just preparing to penetrate a very well-established market.
Thoratec shares gain big today after the heart pump maker reports more than 46% profit growth for the 4th quarter, lifting full-year earnings growth above 34%; also, Accuray soars on Q2 results; Hanger's Q4, 2011 profits soar; Cerner posts double-digit increases for Q4, 2011; Steris posts solid Q3 growth; Misonix swings to Q2 black; Q2 losses double for Cardiovascular Systems; Q2 sales slump, losses gape for pSivida; and DermaGraft sales trickle in for Shire.
Thoratec (NSDQ:THOR) shares are up more than 11% today after the heart pump maker put mid-double-digit profit growth numbers on the board for the 4th quarter and full-year 2011.
The Pleasanton, Calif.-based cardiac assist device maker logged profits of $15.3 million, or 25 cents per diluted share, on sales of $109.4 million for the 3 months ended Dec. 31, 2011. That's a 46.4% bottom-line gain and a top-line boost of 12.1%, compared with profits of $10.5 million, or 17 cents diluted EPS, on sales of $97.6 million during Q4 2010.
The top seven medical device stories for the week of January 2, 2012.
Say hello to MassDevice +7, a bite-sized view of the top seven med-tech stories of the week. This latest feature of MassDevice.com's coverage highlights our seven biggest and most influential stories from the week's news to make sure you're up to date on the headlines that continue to shape the medical device industry.
If you read nothing else this weekend, make sure you're still in the know with MassDevice +7.
The top three medical device stories for January 3, 2012.
Say hello to MassDevice +3, a bite-sized view of the top three med-tech stories of the day. This feature of MassDevice.com's coverage highlights our 3 biggest and most influential stories from the day's news to make sure you're up to date on the headlines that continue to shape the medical device industry.
If you read nothing else today, make sure you're still in the know with MassDevice +3.
Accuray amends a partnership to expand distribution rights for its newly acquired TomoTherapy's devices to Siemens.
Amid job losses and cost cutting measures, Accuray (NSDQ:ARAY) and Siemens AG (NYSE:SI) amended their strategic partnership to allow Siemens to sell CyberKnife products made by Accuray's recent acquisition, TomoTherapy Inc.
Accuray Inc. cuts 29 positions and plans to cut 22 more in order to reduce costs following its merger with TomoTherapy.
Accuray (NSDQ:ARAY) laid off 29 workers and plans to cut another 22 over the next three quarters, reducing its workforce by 5 percent.
The cancer treatment device maker aims to reduce costs following its $277 million acquisition of TomoTherapy Inc. (NSDQ:TOMO).